MUMBAI, India, Aug. 10 -- Intellectual Property India has published a patent application (202411052332 A) filed by Akums Drugs & Pharmaceutical Ltd on January 08, 2025, for Dextromethrophan And Chlorpheniramine Lozenges Composition.
Inventor includes Sanjeev Jain.
The application for the patent was published on July 31, 2026, under issue no. 31/2026.
Abstract: ABSTRACT DEXTROMETHROPHAN AND CHLORPHENIRAMINE LOZENGES COMPOSITION The present invention relates to a novel lozenge formulation containing Dextromethorphan Hydrobromide, Chlorpheniramine Maleate, and optionally Phenylephrine, designed to treat symptoms associated with the common cold, allergies, and cough. This lozenge addresses the limitations of existing dosage forms such as syrups, tablets, and capsules by offering precise dosing, improved portability, and enhanced patient compliance. The lozenge dissolves slowly in the mouth, ensuring steady release and faster onset of action through buccal absorption. Formulated with various pharmaceutically acceptable excipients, the lozenge is palatable, stable, and convenient for on-the-go use. This invention aims to provide a more effective and user-friendly therapeutic option, particularly benefiting pediatric and elderly populations.
Disclaimer: Curated by HT Syndication.
